论文部分内容阅读
目的:分析研究头孢哌酮舒巴坦钠静滴结合雾化治疗老年慢性阻塞性肺疾病(COPD)合并感染的临床效果。方法:选择2013年-2014年接受治疗的86例老年COPD合并感染患者作为研究对象,运用随机数字法将其分为研究组和对照组,各43例,对照组患者单给予头孢哌酮舒巴坦钠静滴,研究组患者在对照组治疗基础上给予头孢哌酮舒巴坦钠雾化治疗。结果:研究组患者的治疗有效率93.0%明显高于对照组的72.0%(P<0.05);研究组患者的症状缓解时间和体温恢复时间明显短于对照组(P<0.05)。结论:治疗老年COPD合并感染采取头孢哌酮舒巴坦钠静滴加雾化,能取得显著疗效。
Objective: To analyze the clinical effect of intravenous cefoperazone and sulbactam combined with nebulization in the treatment of senile chronic obstructive pulmonary disease (COPD) complicated with infection. METHODS: A total of 86 elderly patients with COPD who were treated for treatment from 2013 to 2014 were selected as study subjects. They were divided into study group and control group by random number method, and 43 patients in each group were given cefoperazone Sodium infusion of sodium, the study group was given cefoperazone sulbactam sodium atomization on the basis of the control group. Results: The effective rate of treatment in study group was 93.0%, which was significantly higher than that in control group (72.0%, P <0.05). The symptom relieving time and body temperature recovery time in study group were significantly shorter than those in control group (P <0.05). Conclusion: The treatment of senile COPD infection with cefoperazone sulbactam sodium intravenous infusion, can achieve a significant effect.